Altium Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-90,000
Closed -$5.7M 142
2021
Q3
$5.7M Buy
90,000
+26,566
+42% +$2.02M 1.5% 18
2021
Q2
$5.8M Sell
63,434
-17,850
-22% -$1.42M 1.35% 19
2021
Q1
$5.54M Buy
+81,284
New +$6.31M 1.54% 13

Other funds holding CDNA

Altium Capital Management's CDNA Position: Q4 2021 in Review

Altium Capital Management sold out of CareDx (CDNA) in Q4 2021, closing a stake of 90,000 shares — an estimated $5.7M sold.

Altium Capital Management first reported a position in CDNA in Q1 2021 and held it in 3 quarters. The position peaked at $5.8M in Q2 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.

  • Altium Capital Management reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
  • Altium Capital Management sold 90,000 CareDx shares in Q4 2021, an estimated $5.7M.
  • Altium Capital Management first reported a position in CareDx in Q1 2021 and held it in 3 quarters.
  • Altium Capital Management's CareDx position peaked at $5.8M in Q2 2021.
  • 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.

Based on Altium Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.